GenapSys
Court Approves Genapsys Sale to Sequencing Health
According to the asset purchase agreement, Sequencing Health would offer up to $10 million in cash and assume Genapsys debt of approximately $32 million.
Genapsys Founders Lose Bid to Dismiss Bankruptcy Case
Genapsys has also obtained a minimum bid for its assets worth approximately $42 million, including $10 million in cash and the assumption of debt.
Genapsys Files for Chapter 11 Bankruptcy Protection
The Redwood City, California-based sequencing firm laid off more than 70 employees on July 8 after furloughing nearly all of its employees in late June.
The lawsuits are not the only recent disruption for Genapsys, which laid off approximately 40 employees earlier this year after a $70 million financing in 2021.
ABRF Study Benchmarks NGS Platforms on Human, Microbial Samples, Provides Peek at Genapsys Data
Premium
Illumina's NovaSeq, Oxford Nanopore's Flongle, and Genapsys were among the winners based on the results of the multiyear, multi-center NGS study.